The statistic depicts the leading merger & acquisitions deals announced in the first half of 2018 having any Japanese involvement, by transaction value. In the period examined, the announced acquisition of Shire PLC by the pharmaceutical corporation Takeda Pharmaceutical topped the ranking, with an expected deal value of around 76.89 billion U.S. dollars.
Leading merger & acquisitions deals announced in the first half of 2018 having any Japanese involvement, by transaction value (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Leading M&A announced deals South Korea H1 2018
- Premium Statistic Value of Japanese net cross-border M&A purchases 2013-2022
- Premium Statistic Number of Japanese net cross-border M&A purchases 2013-2022
- Premium Statistic Value of M&A transactions globally 2015-2022, by target country
- Premium Statistic Value of M&A deals North America 1985-2023
- Premium Statistic Value of global M&A transactions 2019-2023, by region
- Premium Statistic Volume of M&A deals Asia-Pacific 1990-2023
- Premium Statistic Value of M&A transactions in the Middle East and North Africa 1990-2023
- Premium Statistic Acquisitions in the United Kingdom: value of foreign transactions Q2 2011- Q4 2022
- Basic Statistic China's media and entertainment sector M&A deals value 2016-2022
About the region
10
- Premium Statistic Softbank's Vision Fund's investments 2018
- Premium Statistic Breakdown Japanese Government Bond holders 2023, by type of holder
- Premium Statistic Japanese industries' investment appeal 2024, by sector
- Premium Statistic Construction order value for medical and welfare institutions in Japan FY 2013-2022
- Premium Statistic Major startups in Japan 2023, by capital raised
- Premium Statistic Total number of IPOs of startups Japan 2014 to 2023
- Premium Statistic Olympus Corporation's revenue share FY 2023, by segment
- Premium Statistic Office real estate acquisition amount of REITs in Japan 2015-2023
- Basic Statistic Terumo's revenue FY 2013-2022
- Premium Statistic Drug production value of cardiovascular agents Japan 2022, by category
Other regions
9
- Premium Statistic Life sciences' leading M&A deals worldwide H1 2018
- Basic Statistic Value of M&As in the U.S. healthcare and life sciences sector 2009-2021
- Basic Statistic Employment in California's life science industry in 2022, by sector
- Premium Statistic Willingness of consumers to use new digital health technologies in England 2018
- Premium Statistic Index rank of barriers to entrepreneurship for select countries 2014
- Premium Statistic Mexico medical device industry production 2016-2020
- Premium Statistic Digital technologies used by life sciences supply chains 2018, by function
- Premium Statistic Highest M&A transactions in the pharmaceutical industry in France H1 2018
- Premium Statistic Market share of medical implants in India as of September 2017 by type
Related statistics
10
- Premium Statistic Production value of prescription drugs Japan 2013-2022
- Premium Statistic Drug production value share of hormones Japan 2021, by category
- Premium Statistic Drug production value of traditional Chinese medicines Japan 2013-2022
- Premium Statistic Annual national medical care expenditure Japan FY 2021, by service
- Premium Statistic Annual national medical expenditure per capita Japan FY 2012-2021
- Premium Statistic Daiichi Sankyo's net income FY 2013-2022
- Premium Statistic Daiichi Sankyo's total assets FY 2012-2021
- Premium Statistic Daiichi Sankyo's total employees FY 2013-2022
- Premium Statistic Daiichi Sankyo's R&D expenditure FY 2013-2022
- Premium Statistic Fuji Pharma's sales distribution FY 2022, by therapeutic category
Further related statistics
10
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- M&A capacities - changes for the global pharma industry 2008-2015
- Biotech company distribution by geographical location
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
Further Content: You might find this interesting as well
Statistics
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- M&A capacities - changes for the global pharma industry 2008-2015
- Biotech company distribution by geographical location
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
Thomson Reuters. (June 28, 2018). Leading merger & acquisitions deals announced in the first half of 2018 having any Japanese involvement, by transaction value (in billion U.S. dollars) [Graph]. In Statista. Retrieved April 25, 2024, from https://www.statista.com/statistics/916693/leading-japanese-involved-announced-merger-and-acquisition-deals-value/
Thomson Reuters. "Leading merger & acquisitions deals announced in the first half of 2018 having any Japanese involvement, by transaction value (in billion U.S. dollars)." Chart. June 28, 2018. Statista. Accessed April 25, 2024. https://www.statista.com/statistics/916693/leading-japanese-involved-announced-merger-and-acquisition-deals-value/
Thomson Reuters. (2018). Leading merger & acquisitions deals announced in the first half of 2018 having any Japanese involvement, by transaction value (in billion U.S. dollars). Statista. Statista Inc.. Accessed: April 25, 2024. https://www.statista.com/statistics/916693/leading-japanese-involved-announced-merger-and-acquisition-deals-value/
Thomson Reuters. "Leading Merger & Acquisitions Deals Announced in The First Half of 2018 Having Any Japanese Involvement, by Transaction Value (in Billion U.S. Dollars)." Statista, Statista Inc., 28 Jun 2018, https://www.statista.com/statistics/916693/leading-japanese-involved-announced-merger-and-acquisition-deals-value/
Thomson Reuters, Leading merger & acquisitions deals announced in the first half of 2018 having any Japanese involvement, by transaction value (in billion U.S. dollars) Statista, https://www.statista.com/statistics/916693/leading-japanese-involved-announced-merger-and-acquisition-deals-value/ (last visited April 25, 2024)
Leading merger & acquisitions deals announced in the first half of 2018 having any Japanese involvement, by transaction value (in billion U.S. dollars) [Graph], Thomson Reuters, June 28, 2018. [Online]. Available: https://www.statista.com/statistics/916693/leading-japanese-involved-announced-merger-and-acquisition-deals-value/